arrow
R

Rita Santoro

azienda ospedaliero-universitaria renato dulbecco
H指数:26
被引数:2,448

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

NuPOWER (Nuwiq for Perioperative management Of patients With haemophilia A on Emicizumab Regular prophylaxis): protocol for an open-label, single-arm, multicentre study
2025-10-270
OA
Contrasting Approaches in the Implementation of GRADE Methodology in Guidelines for Haemophilia and Von Willebrand Disease
2024-12-090
PRE
International Society on Thrombosis and Haemostasis Clinical Practice Guideline for Treatment of Congenital Haemophilia-A Critical Appraisal
2024-12-060
PREAI
Design of an international, phase IV, open-label study of simoctocog alfa in women/girls with hemophilia A undergoing surgery (NuDIMENSION)
2024-12-010
OAAI
Management and Outcomes of Pregnancy and Childbirth in Known and Unknown Hemophilia Carriers: 10 Years Retrospective Evaluation from Southern Italy

已知和未知血友病携带者妊娠与分娩的管理及结局:意大利南部10年回顾性评估

BLOOD
IF23.1
2024-11-050
PRE
More early bleeds associated with high baseline direct oral anticoagulant levels in atrial fibrillation: the MAS study
2024-09-165
OAAI
Pharmacokinetics of Efmoroctocog alfa by Two-Compartment Model Highlights Hemophilia A Patients with Biphasic Decay, Long Mean Residence Time, and Beta Half-Life

Efmorocog alfa的药代动力学通过两室模型突出了具有双相衰变,长平均停留时间和 β 半衰期的血友病A患者

2024-08-230
OAAI
Thrombotic events associated with low baseline direct oral anticoagulant levels in atrial fibrillation: the MAS study
2024-04-107
OAAI
Prolongated Activated Partial Thromboplastin Time (aPTT) in Pediatric Patients before Surgery-Crying Wolf: Lupus (Anticoagulant) Does Not Always Threaten Children

手术前儿科患者的活化部分凝血活酶时间 (aPTT) 延长-哭泣的狼: 狼疮 (抗凝剂) 并不总是威胁儿童

2024-03-060
OAAI
Laying the foundations for gene therapy in Italy for patients with haemophilia A: A Delphi consensus study

为意大利a型血友病患者的基因治疗奠定基础: Delphi共识研究

2022-12-054
OA
D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study

D-二聚体和减量阿哌沙班用于无缘无故静脉血栓栓塞后的延长治疗: Apidulcis研究

2022-11-3014
OAAI
IDEAL study: A real-world assessment of pattern of use and clinical outcomes with recombinant coagulation factor IX albumin fusion protein (rIX-FP) in patients with haemophilia B in Italy

理想研究: 意大利b型血友病患者重组凝血因子IX白蛋白融合蛋白 (rix-fp) 的使用模式和临床结果的真实评估

2022-11-247
OA